Powder: -20°C for 3 years | In solvent: -80°C for 1 year
WZ811 is a novel and effective small molecular CXCR4 antagonist (EC50: 0.3 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 48.00 | |
10 mg | In stock | $ 61.00 | |
25 mg | In stock | $ 116.00 | |
50 mg | In stock | $ 186.00 | |
100 mg | In stock | $ 259.00 | |
200 mg | In stock | $ 336.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 57.00 |
Description | WZ811 is a novel and effective small molecular CXCR4 antagonist (EC50: 0.3 nM). |
Targets&IC50 | CXCR4:0.3 nM(EC50) |
In vivo | WZ811 markedly inhibits the reduction of cAMP caused by SDF-1. It also demonstrates inhibitory effects on SDF-1-mediated invasion with an EC50 value of 5.2 nM. |
Molecular Weight | 290.36 |
Formula | C18H18N4 |
CAS No. | 55778-02-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 28 mg/mL (96.4 mM)
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
WZ811 55778-02-4 Autophagy GPCR/G Protein Immunology/Inflammation CXCR Inhibitor inhibit WZ-811 WZ 811 CXC chemokine receptors inhibitor